GLP-1 Medications May Lower Dementia Risk, Research Shows

Although glucagon-like peptide-1 (GLP-1) receptor agonists are primarily intended for managing type 2 diabetes (T2D) and obesity, research continues to uncover additional benefits. The latest exploration suggests that GLP-1 medications may help lower dementia risk.